Posted on October 27, 2020 by Sitemaster
New data on this topic — from a Phase II/III clinical trial — have just been presented at the virtual annual meeting of the American Society for Radiation Oncology (ASTRO). Basically, the data from this study by Sahgal et al. indicated that 24 Gy (in two 12 Gy doses) of stereotactic body radiation therapy (SBRT) was more effective in the elimination of spinal pain in patients with metastatic cancer as compared to 20 Gy (in five 4 Gy doses) of conventional, external beam radiation therapy (EBRT).
… READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: bone, EBRT, metastatic, pain, radiation, SBRT, spine | 3 Comments »
Posted on September 17, 2019 by Sitemaster
Stereotactic ablative body radiation (SABR, or sometimes, SBRT) significantly slowed metastatic progression in men with three or fewer metastases (oligometastatic disease). … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: ablative, body, oligometastasis, radiation, SABR, SBRT, stereotactic | 5 Comments »
Posted on April 25, 2019 by Sitemaster
Last year, the American Society of Radiation Oncologists (ASTRO) looked at the available evidence comparing hypofractionated radiotherapy (either 60 Gy in 20 treatments or 70 Gy in 28 treatments) to standard fractionation (78 to 82 Gy in 40 to 44 treatments), and found it was at least as good in terms of oncological outcomes and toxicity. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: body, intermediate risk, low risk, radiation, SBRT, stereotactic | 1 Comment »
Posted on February 18, 2019 by Sitemaster
In October 2018, the American Society of Radiation Oncologists (ASTRO) strongly endorsed moderately hypofractionated IMRT (20 or 28 treatments) for primary radiation treatment (see this link). … READ MORE …
Filed under: Uncategorized | Tagged: adverse, events, hypofractionation, safety, SBRT | 3 Comments »
Posted on January 9, 2019 by Sitemaster
While excellent outcomes of stereotactic body radiation therapy (SBRT) have been reported since it was first used to treat prostate cancer in 2003, the delivered doses have ranged from 35 Gy in five treatments to 40 Gy in five treatments. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: body, dose, optimal, radiation, SBRT, stereotactic | 6 Comments »
Posted on October 26, 2018 by Sitemaster
Stereotactic body radiation therapy or SBRT (sometimes referred to as SABR or SHARP or CyberKnife) has had excellent 7-year outcomes in an update of the consortium study, including data from 10 single-institution trials and two multi-institutional trials. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: body, intermediate, low, radiation, risk, SBRT, sterotactic | 10 Comments »
Posted on September 10, 2018 by Sitemaster
Meier et al. have just published updated results of a 5-year multi-institutional trial finding that stereotactic body radiation therapy (SBRT) had high rates of cancer control and low toxicity. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: bod, outcomes, radiation, SBRT, stereotactic | 6 Comments »
Posted on June 21, 2018 by Sitemaster
We first reported data from the results of the RTOG 0938 trial in January 2016 when they were presented at the Genitourinary Cancers Symposium in that year. These results have now been formally published, and there are some changes to the data on publication, so Allen Edel has provided an update. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: body, hypofractionated, radiation, SBRT, stereotactic, toxicity | Leave a comment »
Posted on May 1, 2018 by Sitemaster
In the first trial ever to randomly assign patients to extreme hypofractionation, primary radiation therapy delivered in just seven treatments had the same effectiveness and safety as 39 treatments. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: 3D-CRT, body, conventional, outcome, radiation, randomized, SBRT, stereotactic, trial | 2 Comments »
Posted on January 28, 2018 by Sitemaster
The University of California, Los Angeles (UCLA) has announced a new clinical trial using stereotactic body radiation therapy (SBRT) for treatment of recurrent prostate cancer after failure of initial prostatectomy. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: body, radiation, salvage, SBRT, stereotactic | 3 Comments »
Posted on September 18, 2017 by Sitemaster
Alan Katz has now published the study with the longest-running follow-up of any study of external beam radiation therapy for prostate cancer among low-risk patients, in this case using SBRT. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: 10-year, body, follow-up, SBRT, stereotactic | 2 Comments »
Posted on August 29, 2017 by Sitemaster
A group of researchers at Memorial Sloan-Kettering Cancer Center (MSKCC) reported in 2014 (see this link) on the outcomes of 42 patients with radio-recurrent prostate cancer treated with salvage high-dose-rate brachytherapy (sHDR-BT). The results were quite good — … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: brachytherapy, high-dose-rate, low-dose-rate, radiation, salvage, SBRT, stereotactic | Leave a comment »
Posted on July 7, 2017 by Sitemaster
In a recent commentary (see this link), we saw that some clinicians are making unsubstantiated claims of cancer control from treatment of oligometastases (less than 5 detected metastases). … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: body, oligometastatic, radiation, SBRT, stereotactic, trial | 16 Comments »
Posted on May 4, 2017 by Sitemaster
Many patients wonder, if they just have a couple of metastases, why can’t those be “zapped” by a few quick SBRT treatments and they can’t thereby be cured of their prostate cancer? Or, even if they can’t be cured, can’t the cancer’s progression be slowed down? … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: efficacy, oligometastatic, outcome, radiation, SBRT | 8 Comments »
Posted on May 2, 2017 by Sitemaster
Is there an optimum treatment dose for sterotactic body radiation therapy (SBRT)? … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: dose, effectiveness, escalation, SABR, safety, SBRT | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 